Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids

ABSTRACT: RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids

PROVIDER: PRJNA531430 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8864230_1.fastq.gz	Fastqsanger.gz
	SRR8864230_2.fastq.gz	Fastqsanger.gz
	SRR8864240_1.fastq.gz	Fastqsanger.gz
	SRR8864240_2.fastq.gz	Fastqsanger.gz
	SRR8864231_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 38

Similar Datasets

RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids

Project description:Liver organoids were engineered by CRISPR/Cas9 to introduce mutation in the BAP1 gene and profiled for changes in RNA expression, chromatin accessibility and histone marks

2019-05-22 | GSE129457 | GEO

Probing the Tumour Suppressor Function of BAP1 in CRISPR-engineered Human Liver Organoids

Project description:The deubiquitinating enzyme BAP1 is a tumour suppressor, amongst others involved in cholangiocarcinoma. BAP1 has many proposed molecular targets, while its Drosophila homolog is known to deubiquitinate Histone H2AK119. Here, we mutate BAP1 by CRISPR/Cas9 in normal human liver organoids. We find that BAP1 controls the expression of junctional/cytoskeleton components by regulating chromatin accessibility. Consequently, we observe loss of multiple epithelial characteristics, while motility increases. Importantly, restoring the catalytic activity of BAP1 in the nucleus rescues these cellular and molecular changes. We engineer human liver organoids to combine four common cholangiocarcinoma mutations (TP53, PTEN, SMAD4, NF1). In this genetic background, BAP1 loss results in acquisition of malignant features upon xenotransplantation. Thus, control of epithelial identity through the regulation of chromatin accessibility appears a key aspect of BAP1’s tumour suppressor function. Organoid technology combined with CRISPR/Cas9 provides an experimental platform for mechanistic studies of cancer gene function in a human context.

2019-05-22 | PXD013353 | Pride

Deoxyshikonin-induced chromatin accesibility changes in porcine intestinal epithelial cells

Project description:The objectives of this study is to evaluate the chromatin accesibility changes after deoxyshikonin stimulation in porcine intestinal epithelial cells.

2023-04-09 | GSE228772 | GEO

Chromatin accesibility in mice T-ALL tumors

Project description:Long-range enhancers play an important role in the temporal and spatial control of gene expression and are deregulated in many cancers. Yet, the mechanisms that govern enhancer activity during development and oncogenesis remain poorly understood. In this study we analyze the chromatin accesibility of mice T-ALL tumors.

2018-12-21 | GSE124175 | GEO

Bap1 and RNF2 ChIP-seq in mES cells

Project description:Malignancies arising from mutation of tumor suppressor genes display an unexplained tissue proclivity. For example, tumor suppressor BAP1 encodes a ubiquitously expressed deubiquitinase for histone H2A but germline mutations predominantly cause uveal melanomas and mesotheliomas. We show that BAP1 inactivation causes apoptosis in mouse embryonic stem cells, fibroblasts, liver and pancreas, whereas melanocytes and mesothelial cells remain viable. E3 ligase RNF2, which silences genes by monoubiquitinating H2A, promoted apoptosis in BAP1-deficient cells by suppressing the pro-survival genes Bcl-2 and Mcl-1. Our data argue that BAP1 modulates gene expression by countering H2A ubiquitination, but its loss only promotes tumorigenesis in cells that do not engage an RNF2-dependent apoptotic program. We propose that intolerance of BAP1 loss, and perhaps the loss of other tumor suppressors, restricts the mutant tumor spectrum.

2019-03-26 | GSE120302 | GEO

Effect of the depletion of RBP33 (Tb927.8.990) on chromatin accesibility in bloodstream Trypanosoma brucei [ATAC-seq]

Project description:Depletion of RBP33 by RNAi does not seem to have profound effects on chromatin accesibility

2022-11-03 | GSE186562 | GEO

Chromatin accesibility in mice T-ALL tumors

Project description:Chromatin accesibility in mice T-ALL tumors

| PRJNA510948 | ENA

Chromatin accesibility in human DP3 thymocytes and T-ALL tumors

2018-12-21 | GSE124223 | GEO

Organoids-on-a-chip for Colorectal Cancer and in Vitro Screening of Chemotherapeutic Drugs

Project description:The individualized treatment of tumors has always been an urgent problem in clinical practice. Organoids-on-a-chip can reflect the heterogeneity of tumors and is a good model for in vitro anticancer drug screening. In this study, surgical specimens of patients with advanced colorectal cancer will be collected for organoid culture and organoids-on-a- chip. Use organoids-on-a-chip to screen tumor chemotherapy drugs, compare the results of patients’ actual medication regimens, and study the guiding role of organoids in the formulation of precise tumor treatment plans. The investigators will compare the response of organoids to drugs in vitro with the patient’s response to actual chemotherapy and targeted drugs and explore the feasibility and accuracy of organoids-on-a-chip based drug screening for advanced colorectal cancer. The project will establish a screening platform for chemotherapeutic drugs and targeted drugs based on colorectal cancer organoids to quickly and accurately formulate personalized treatment plans for clinical patients.

| 2385953 | ecrin-mdr-crc

RNAseq in protected BAP1 mESc

2019-03-26 | GSE120413 | GEO